Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis
Background. Nephroblastoma (Wilms tumour) is one of the most common solid tumours of all paediatric cancers (prevalence of 5% globally and 13.5% in South Africa (SA)), with suboptimal survival outcomes, impacting children’s lives. Consequently, there is an urgent need for enhanced early detecti...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Medical Association
2024-11-01
|
Series: | South African Medical Journal |
Subjects: | |
Online Access: | https://samajournals.co.za/index.php/samj/article/view/2223 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823860609611988992 |
---|---|
author | E Brits E Gerber I Iroka L Mgidlana J Willoughby S Dhlamini P Nxumalo S Sefadi A Mthembu J B Sempa |
author_facet | E Brits E Gerber I Iroka L Mgidlana J Willoughby S Dhlamini P Nxumalo S Sefadi A Mthembu J B Sempa |
author_sort | E Brits |
collection | DOAJ |
description |
Background. Nephroblastoma (Wilms tumour) is one of the most common solid tumours of all paediatric cancers (prevalence of 5% globally and 13.5% in South Africa (SA)), with suboptimal survival outcomes, impacting children’s lives. Consequently, there is an urgent need for enhanced early detection strategies, addressing survival rate disparities and late-stage presentations to improve outcomes.
Objectives. To assess profiles, disease presentations, management and outcomes of patients with nephroblastoma at Universitas Academic Hospital Complex (UAHC), and to compare patients from SA and Lesotho, including differences between early and late presenters and reasons for delayed presentation.
Methods. This retrospective cross-sectional study included 207 paediatric oncology patients treated for nephroblastoma at the Paediatric Haematology and Oncology Unit at UAHC, Bloemfontein, SA, from January 2000 to December 2020.
Results. The median age of the study population was 38 months, with a marginal male predominance (50.7%). A 1-month delay occurred between symptom onset and diagnosis, commonly attributed to delayed care-seeking, impacting survival rates. Compared with similar SA studies, a higher stage IV disease rate (29.5%) was observed, and encouraging survival rates (59.4%) correlated with favourable preoperative histology and no relapse. In comparison, Lesotho patients experienced longer delays and presented with more severe disease.
Conclusion. This study highlights the need for collaboration between SA and Lesotho healthcare providers to improve outcomes by addressing diagnostic delays, treatment defaults and response variations in resource-limited settings through community health education, improving access to primary care, offering care-provider training, improving diagnostic resources and addressing socioeconomic barriers.
|
format | Article |
id | doaj-art-dfb5a03da153474cab8c084f06619428 |
institution | Kabale University |
issn | 0256-9574 2078-5135 |
language | English |
publishDate | 2024-11-01 |
publisher | South African Medical Association |
record_format | Article |
series | South African Medical Journal |
spelling | doaj-art-dfb5a03da153474cab8c084f066194282025-02-10T12:25:28ZengSouth African Medical AssociationSouth African Medical Journal0256-95742078-51352024-11-011141210.7196/SAMJ.2024.v114i12.2223Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysisE Brits0E Gerber1I Iroka2L Mgidlana3J Willoughby4S Dhlamini5P Nxumalo6S Sefadi7A Mthembu8J B Sempa9Department of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaDepartment of Biostatistics, School of Biomedical Sciences, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa Background. Nephroblastoma (Wilms tumour) is one of the most common solid tumours of all paediatric cancers (prevalence of 5% globally and 13.5% in South Africa (SA)), with suboptimal survival outcomes, impacting children’s lives. Consequently, there is an urgent need for enhanced early detection strategies, addressing survival rate disparities and late-stage presentations to improve outcomes. Objectives. To assess profiles, disease presentations, management and outcomes of patients with nephroblastoma at Universitas Academic Hospital Complex (UAHC), and to compare patients from SA and Lesotho, including differences between early and late presenters and reasons for delayed presentation. Methods. This retrospective cross-sectional study included 207 paediatric oncology patients treated for nephroblastoma at the Paediatric Haematology and Oncology Unit at UAHC, Bloemfontein, SA, from January 2000 to December 2020. Results. The median age of the study population was 38 months, with a marginal male predominance (50.7%). A 1-month delay occurred between symptom onset and diagnosis, commonly attributed to delayed care-seeking, impacting survival rates. Compared with similar SA studies, a higher stage IV disease rate (29.5%) was observed, and encouraging survival rates (59.4%) correlated with favourable preoperative histology and no relapse. In comparison, Lesotho patients experienced longer delays and presented with more severe disease. Conclusion. This study highlights the need for collaboration between SA and Lesotho healthcare providers to improve outcomes by addressing diagnostic delays, treatment defaults and response variations in resource-limited settings through community health education, improving access to primary care, offering care-provider training, improving diagnostic resources and addressing socioeconomic barriers. https://samajournals.co.za/index.php/samj/article/view/2223ChildrenCancer |
spellingShingle | E Brits E Gerber I Iroka L Mgidlana J Willoughby S Dhlamini P Nxumalo S Sefadi A Mthembu J B Sempa Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis South African Medical Journal Children Cancer |
title | Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis |
title_full | Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis |
title_fullStr | Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis |
title_full_unstemmed | Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis |
title_short | Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis |
title_sort | paediatric nephroblastoma at a south african tertiary hospital a 21 year retrospective analysis |
topic | Children Cancer |
url | https://samajournals.co.za/index.php/samj/article/view/2223 |
work_keys_str_mv | AT ebrits paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT egerber paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT iiroka paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT lmgidlana paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT jwilloughby paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT sdhlamini paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT pnxumalo paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT ssefadi paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT amthembu paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis AT jbsempa paediatricnephroblastomaatasouthafricantertiaryhospitala21yearretrospectiveanalysis |